Overview


According to FutureWise analysis the market for cell therapy in 2023 is US$ 17.75 billion, and is expected to reach US$ 72.34 billion by 2031 at a CAGR of 19.40%.

Cell therapy, also known as cell-based therapy or cellular therapy, is a type of medical treatment that involves the use of living cells to treat or cure diseases. The cells employed in cell therapy can be sourced from the patient's own body (autologous) or from a donor (allogeneic), and they are typically either primary cells or stem cells. Cell therapy aims to either replace damaged or diseased cells with healthy ones, stimulate the body's healing process, or modify the immune system to better target cancer or other diseases. Cell therapy has the potential to treat a wide range of diseases, such as cancer, autoimmune disorders, genetic disorders, cardiovascular disease, and neurological disorders, among others. It is particularly promising for conditions that do not respond well to traditional therapies, such as chemotherapy or radiation therapy, or for patients who are not suitable candidates for these treatments due to their age or other health issues.

One example of cell therapy is CAR-T cell therapy, which is used to treat certain types of cancer. In this treatment, T-cells (a type of immune cell) are taken from the patient's blood, genetically modified in a lab to target cancer cells, and then infused back into the patient's body to seek out and destroy cancer cells. Another example of cell therapy is mesenchymal stem cell therapy, which is being studied for its potential to treat conditions such as osteoarthritis, multiple sclerosis, and heart disease. In this treatment, stem cells are taken from the patient's adipose tissue or bone marrow and administered into the affected area to promote tissue regeneration and reduce inflammation.

FutureWise Market Research has published a report that provides an insightful analysis of Cell Therapy Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Cell Therapy Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Kolon Tissue Gene Inc.
  • Osiris Therapeutics Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • NuVasive Inc.
  • Pharmicell Co Ltd.
  • Vericel Corporation
  • Fibrocell Science Inc.
  • Anterogen.Co. Ltd
  • Stemedica Cell Tecnologies Inc.
  • Pharmicell Co. Ltd.
  • Medipost Co. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Cell Therapy Market:

In January 2022, the Food and Drug Administration approved the treatment of unresectable or metastatic uveal melanoma with Immunocore's KIMMTRAK (tebentafusp-tebn).

The cell therapy market has seen significant expansion in recent years, which is anticipated to continue to expand in the coming years. One of the main drivers of this growth is the increasing prevalence of chronic illnesses, such as cancer and autoimmune disorders, which have led to a rise in demand for innovative treatments that can address these conditions. Additionally, advances in technology and an improved understanding of the biology of cells have paved the way for the development of new and more effective cell therapies. The market for cell therapy is highly competitive, with a large number of firms vying for a share of the market. Large pharmaceutical companies, biotech firms, and startups are all investing heavily in this field. This has led to an increase in mergers and acquisitions as corporations seek to extend their product portfolios and gain access to new technologies. The regulatory environment also plays a significant role in the growth of the cell therapy market. As the industry is still relatively new, regulators are continuously updating guidelines and standards to ensure the safety and efficacy of cell therapies. This has led to increased scrutiny of companies' manufacturing processes and clinical trial data, which can make it challenging for smaller companies to navigate the regulatory landscape.

Despite these challenges, the outlook for the cell therapy market remains positive. Advancements in technology, a growing demand for innovative treatments, and an increasing focus on personalized medicine are all expected to drive growth in the coming years. However, the market is likely to face several hurdles along the way, including regulatory challenges, manufacturing hurdles, and pricing pressures.

By Cell Type

  •  Stem Cell
    •        Bone Marrow
    •        Blood
    •        Umbilical Cord-Derived
    •        Adipose-Derived Stem Cell
    •        Others
  •  Non-stem Cell 

By Therapy Type

  • Autologous
  • Allogeneic

By Therapeutic

  • Malignancies
  • Musculoskeletal Disorders
  • Autoimmune Disorders
  • Dermatology
  • Other

By End User

  • Hospital & Clinics
  • Academic & Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. Due to a robust regulatory environment supporting cellular therapy development, key players in the industry, and prestigious universities supporting research activities in the United States, North America is predicted to retain the largest share of the global market for cell therapy. The rising frequency of chronic diseases, expanding use of regenerative medicine, and the rising number of clinical studies on the development of cellular treatments are all contributing factors to the market's rapid expansion. According to estimates, the North American industry will be fueled by rising investments by industry participants in the development and use of cell-based treatments in the country. For instance, Cellino Biotech, a manufacturer of cell therapies, raised USD 80 million in a Series A investment round in January 2022. To create the first autonomous human cell foundry by 2025, Cellino intends to increase access to stem cell-based medicines. The factors anticipated to propel the growth of this market in North America are increased investments and research activities by the main industry players and successful cell treatments

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cell Therapy Market By Cell Type, By Therapy Type, By Therapeutic, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific , Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cell Therapy Market Variables, Trends and Scope

    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cell Therapy Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cell Therapy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cell Therapy Market, By Cell Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Stem Cell
         1.1. Bone Marrow
         1.2. Blood
         1.3. Umbilical Cord-Derived
         1.4. Adipose-Derived Stem Cell
         1.5. Others
        2. Non-stem Cell

  • 8.   Cell Therapy Market, By Therapy Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Autologous
        2. Allogeneic

  • 9.   Cell Therapy Market, By Therapeutic Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Malignancies
        2. Musculoskeletal Disorders
        3. Autoimmune Disorders
        4. Dermatology
        5. Other

  • 10.   Cell Therapy Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital and Clinics
        2. Academic and Research Institutes

  • 11.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Cell Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)

    •   1. Kolon Tissue Gene Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Osiris Therapeutics Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. JCR Pharmaceuticals Co. Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. NuVasive Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Pharmicell Co Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Vericel Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Fibrocell Science Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Anterogen.Co. Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Stemedica Cell Tecnologies Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Pharmicell Co. Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Medipost Co. Ltd.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11